Grant of Stock Acquisition Rights to Directors and Executive Officers
First written in FY2017-Q3. 1 of 3 entries say "Restated". Latest entry: FY2018-Q2.
- FY2018-Q2AdvancedAnnual report
「The stock acquisition rights issued during the current second-quarter accounting period are as follows: 2,158 stock acquisition rights, representing 215,800 underlying shares.」
On 24 August 2017, the Company granted an additional 2,158 stock acquisition rights representing 215,800 shares to its directors and executive officers and the directors and others of its major subsidiaries. The exercise period is from 25 August 2017 to 24 August 2047. - FY2017RestatedAnnual report
「Dai-ichi Life Holdings, Inc. First Series Stock Acquisition Rights」
The stock acquisition rights plan for directors, executive officers and others of the holding company and its major subsidiaries continued to be disclosed in the full-year filing. - FY2017-Q3First statedAnnual report
「The stock acquisition rights issued during the current third-quarter accounting period are as follows: 2,696 stock acquisition rights, representing 269,600 underlying shares. The holders may exercise the stock acquisition rights only within 10 days from the day following the date on which they cease to hold any of the positions of director of the Company, excluding directors who are Audit and Supervisory Committee members, executive officer of the Company, director of Dai-ichi Life Insurance Company, Limited, executive officer of Dai-ichi Life Insurance Company, Limited, director of Dai-ichi Frontier Life Insurance Company, Limited, executive officer of Dai-ichi Frontier Life Insurance Company, Limited, director of Neo First Life Insurance Company, Limited, or executive officer of Neo First Life Insurance Company, Limited.」
The Company issued 2,696 stock acquisition rights representing 269,600 shares to directors and executive officers of the holding company and its major subsidiaries. The exercise period is from 19 October 2016 to 18 October 2046, establishing an executive incentive arrangement linked to long-term share value.